Citi Turns Bullish on Marvell Ahead of CES
Citi sees Marvell’s post-earnings dip as a buying chance, driven by AI data centers and strong growth outlook for 2026–2027.
Already have an account? Sign in.
Citi sees Marvell’s post-earnings dip as a buying chance, driven by AI data centers and strong growth outlook for 2026–2027.
FDA issues Complete Response Letter rejecting RGX-121 gene therapy for Hunter syndrome, citing trial design concerns. Regenxbio plans to resubmit with additional data.
Roth Capital upgrades Roblox to Buy with an $84 price target, citing strong bookings growth, improved game quality, and rising older player engagement.
President Trump endorses Nexstar's $6.2B Tegna acquisition, reversing earlier criticism. Deal would create largest local TV operator covering 80% of U.S. households.